A bill introduced in the Vermont House would decriminalize the possession and cultivation of psilocybin-containing mushrooms for adults 21 and older and establish a state-recognized therapeutic consultation program overseen by licensed health providers.

H.452, introduced by Rep. Brian Cina, (P/D – Chittenden-15), would remove state criminal penalties for adult possession, home cultivation, and noncommercial personal use of psilocybin mushrooms. The proposal does not create a retail marketplace or commercial licensing system. Its focus is limited to personal use and a structured therapeutic framework.

🍁 Make a One-Time Contribution — Stand Up for Accountability in Vermont 🍁

Decriminalization for Adults 21 and Older

Under the bill, adults age 21 and older could possess and cultivate psilocybin-containing mushrooms for noncommercial purposes without facing state criminal charges. The introduced version does not specify quantity limits or detailed enforcement changes, which would be addressed in subsequent drafts.

The measure does not authorize retail sales, dispensaries, or commercial distribution. It is limited to personal possession and cultivation.

Psilocybin Therapeutic Consultation Program

In addition to decriminalization, H.452 would establish a Psilocybin Therapeutic Consultation Program tasked with developing an education, training, and consultation model for safe use.

The program would be designed and overseen by licensed health providers. Eligible providers could include licensed mental health professionals, physicians, nurse practitioners, and other qualified healthcare practitioners as determined by the program. Participating providers would be required to complete certified training focused on psilocybin use, safety protocols, and integration practices.

Licensed providers operating within the program could conduct initial health evaluations to determine whether a patient is an appropriate candidate for psilocybin use. They could also facilitate guided psilocybin sessions in a controlled setting protected under state law and provide post-session integration support intended to help patients process the experience in a therapeutic context.

The structure outlined in the bill centers on supervised, provider-led use rather than recreational access.

Implementation Details to Be Determined

H.452 was introduced as a short-form bill, meaning the detailed statutory language has not yet been drafted. Key implementation questions remain unresolved, including which state agency would oversee the program, how provider licensure would be administered, whether the program would be funded through fees or legislative appropriations, and how Vermont’s controlled substance statutes would be amended.

Those details are typically developed during committee review and incorporated into later versions of the legislation. Lawmakers may also request a fiscal note to evaluate potential administrative costs.

Federal Context and Other States

Psilocybin remains classified as a Schedule I controlled substance under federal law. While states may modify their own criminal penalties, federal classification does not change.

Several jurisdictions have taken steps in recent years to reduce penalties or create regulated therapeutic models. Oregon established a licensed psilocybin services program allowing supervised administration in approved facilities. Colorado voters approved a measure permitting regulated access and decriminalizing personal possession of certain psychedelic substances. Other states and municipalities have adopted policies deprioritizing enforcement of psilocybin possession laws.

H.452 reflects a narrower approach focused on decriminalization of personal use and the development of a healthcare-centered consultation framework.

Legislative Outlook

The bill has been referred to committee for further consideration. During that process, lawmakers are expected to hear testimony from healthcare providers, law enforcement officials, mental health advocates, and members of the public. Amendments could define possession limits, clarify regulatory authority, establish oversight mechanisms, or address funding.

If enacted, the measure would remove state-level criminal penalties for adult possession and home cultivation of psilocybin mushrooms while creating a structured pathway for supervised therapeutic use under trained providers. The scope and regulatory detail will depend on how the bill evolves during committee deliberations.

If you found this information valuable and want to support independent journalism in Vermont, become a supporter for just $5/month today!

Dave Soulia | FYIVT

You can find FYIVT on YouTube | X(Twitter) | Facebook | Instagram

#fyivt #Vermont #VTleg #Psilocybin

Support Us for as Little as $5 – Get In The Fight!!

Make a Big Impact with $25/month—Become a Premium Supporter!

Join the Top Tier of Supporters with $50/month—Become a SUPER Supporter!